Authors

GAOZHONG LI1,2, GUANGSHENG ZHAI3, HONG TAO4, JINGMEI CAO2, XIULIAN WANG2, ZHAOSHENG CHEN1, MIN LI2, KUNMING HUANG2, JIANQIANG GUO1

Departments

1Department of Gastroenterology, the second hospital of Shandong University, No. 247 of Beiyuan Street, Jinan 250033, Shandong Province, China - 2Department of Gastroenterology, Zibo Central Hospital, No. 54 West of Gongqingtuan Road, Zhangdian District, Zibo 255036, Shandong Province, China - 3Department of Radiotheraphy, Zibo Central Hospital, No. 54 West of Gongqingtuan Road, Zhangdian District, Zibo 255036, Shandong Province, China - 4Division of Clinical Skill Training Center, Zibo Central Hospital, No. 54 West of Gongqingtuan Road, Zhangdian District, Zibo 255036, Shandong, China

Abstract

Objective: Our study was designed to investigate the protective effects of parthenolide on hepatic injury in rats with severe acute pancreatitis (SAP).

Methods: The SAP rat models were prepared and randomly devided into five groups,the model control group, parthenolide treated group with different doses of parthenolide, and the sham operated group. The levels of AMY, ALT, AST, IL-6 and TNF-α in serum, NF-κB expression and hepatic pathological changes in all groups were detected.

Results: The levels of AMY, ALT, AST, IL-6 and TNF-α in serum and expression levels of NF-κB were lower in parthenolide treated groups than that in model control group. The model control group showed obviously pathological changes compared with sham group, while the administration of parthenolide dose-dependently inhibited the changes.

Conclusion: Parthenolide demonstrated a well curative capability on rats with SAP.

Keywords

Severe acute pancreatitis; parthenolide; TNF-α; IL-6; NF-κB

DOI:

10.19193/0393-6384_2018_2_79